A novel viral-gene therapy could improve results from breast reconstruction surgery after cancer treatment by helping healthy tissue protect itself from radiotherapy damage.
Browsing: Disease Area > Breast
An innovative new platform could transform the way cancer is diagnosed and treated by automating the isolation of circulating tumor cells.
From clinical trial results to major drug approvals, here we present an overview of the latest industry news from the biggest players in oncology.
Right now, doctors can’t tell whether women with DCIS will go on to develop breast cancer. This means that, unfortunately, some women with DCIS undergo unnecessary treatment. Find out how Jelle and his team are looking to change this.
The FDA has expanded the label for AstraZeneca’s oral PARP inhibitor olaparib to include the treatment of patients with metastatic breast cancer whose disease is associated with a BRCA gene mutation.
How do factors such as night work and light-at-night exposure increase a woman’s breast cancer risk? Find out in this editorial from Breast Cancer Management.
Meta-analysis suggests long-term night shift work increases cancer risk amongst female workers, especially for nurses.
Researchers have demonstrated that neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer (TNBC) to immune checkpoint therapy.